Rockwell Medical (RMTI) Cash from Investing Activities Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Rockwell Medical | 27.99 Mn | 4.10 Mn | 2.90 Mn | -12,100.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,100.00% |
| Dec 31, 2025 | -1,144.28% |
| Sep 30, 2025 | 29.50% |
| Jun 30, 2025 | -106.00% |
| Mar 31, 2025 | 99.28% |
| Dec 31, 2024 | -116.53% |
| Sep 30, 2024 | 40.61% |
| Jun 30, 2024 | 2,782.81% |
| Mar 31, 2024 | -102.62% |
| Dec 31, 2023 | -37.60% |
| Sep 30, 2023 | 29.97% |
| Jun 30, 2023 | -25.49% |
| Mar 31, 2023 | -41.95% |
| Dec 31, 2022 | 495.93% |
| Sep 30, 2022 | -977.42% |
| Jun 30, 2022 | -103.10% |
| Mar 31, 2022 | 1,883.79% |
| Dec 31, 2021 | -15.23% |
| Sep 30, 2021 | -172.75% |
| Jun 30, 2021 | 187.33% |